September 2026
1. MAHARJAN CK, Liu Y, Xiao Y, Podder BR, et al
   PROTAC-mediated targeting of IKKbeta and NR4A1 for AML therapy.
   Oncogene. 2026;45:3921-3934.
   

   >> Share

   
   August 2026
2. PANDA S, Wang Y, Dogiparthi VR, Becker M, et al
   The Inv(16) Oncogene CBFB::MYH11 is Required for the Survival of Leukemia Cells in the Blood and Spleen, but not the Bone Marrow.
   Oncogene. 2026 Aug 17. doi: 10.1038/s41388-026-03956.
   

   >> Share

   
   June 2026
3. ZHU Y, Liu H, Wang F, Li M, et al
   Targeting mitochondrial TRIP13-AIF interaction suppresses myeloid leukemia progression and overcomes drug resistance.
   Oncogene. 2026 Jun 13. doi: 10.1038/s41388-026-03852.
   

   >> Share

   
   May 2026
4. DELAHAYE MC, Leonard S, Pelletier J, Destin J, et al
   Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia.
   Oncogene. 2026 May 23. doi: 10.1038/s41388-026-03827.
   

   >> Share

   
   April 2026
5. HAYASHIDA H, Masamoto Y, Oyama T, Hino T, et al
   Genome-wide screening identifies ZFP91 as a key regulator of EVI1 in myeloid leukemia.
   Oncogene. 2026 Apr 25. doi: 10.1038/s41388-026-03727.
   

   >> Share

   
   
6. BAI J, Araki K, Kurotaki D, Eerdunduleng, et al
   Trisomy 8 alters chromatin conformations and activates Y chromosome genes in stem cells to drive a pre-leukemic state.
   Oncogene. 2026 Apr 4. doi: 10.1038/s41388-026-03763.
   

   >> Share

   
   December 2025
7. MA X, Li Y, Sun W, Lou J, et al
   Super-enhancer-associated long noncoding RNA lnc-SPI1U mediates SPI1 feedback regulation by interacting with HNRNPH1 and HNRNPF.
   Oncogene. 2025;44:4626-4638.
   

   >> Share

   
   November 2025
8. GUO W, Wang X, Cui G, Schmieder EAS, et al
   Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model.
   Oncogene. 2025 Nov 26. doi: 10.1038/s41388-025-03630.
   

   >> Share

   
   September 2025
9. BOVE G, Babaei M, Bueno-Costa A, Amin S, et al
   METTL16-mediated inhibition of MXD4 promotes leukemia through activation of the MYC-MAX axis.
   Oncogene. 2025 Sep 14. doi: 10.1038/s41388-025-03563.
   

   >> Share

   
   August 2025
10. WAGSTAFF M, Sevim O, Goff A, Raynor M, et al
    beta-Catenin interacts with canonical RBPs including MSI2 to associate with a Wnt signalling mRNA network in myeloid leukaemia cells.
    Oncogene. 2025;44:2490-2503.
    

    >> Share

    
    June 2025
11. LIU J, Xu J, Sun R, Wang X, et al
    MARCH1, transcriptionally regulated by POU2F2, facilitates acute myeloid leukemia progression via inducing MYCT1 degradation.
    Oncogene. 2025 Jun 18. doi: 10.1038/s41388-025-03464.
    

    >> Share

    
    
12. LI YQ, Liu D, Wang LL, Shao YL, et al
    WTAP-mediated m(6)A methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML.
    Oncogene. 2025;44:1504-1516.
    

    >> Share

    
    
13. XIE Y, Zhao R, Zheng Y, Li Y, et al
    Targeting KPNB1 suppresses AML cells by inhibiting HMGB2 nuclear import.
    Oncogene. 2025;44:1646-1661.
    

    >> Share

    
    May 2025
14. YAO L, Zhang X, Li X, Xu J, et al
    circAFF2 promotes the development of AML by binding to PML mRNA.
    Oncogene. 2025;44:1234-1244.
    

    >> Share

    
    March 2025
15. ZHANG L, Wang X, Hu D, Li S, et al
    SUMOylation facilitates the stability of BCR-ABL to promote chronic myeloid leukemia progression.
    Oncogene. 2025 Mar 27. doi: 10.1038/s41388-025-03350.
    

    >> Share

    
    February 2025
16. TIAN X, Zhang L, Xiang G, Tang Y, et al
    Single-cell multiomics reveals a gene regulatory circuit driving leukemia cell differentiation.
    Oncogene. 2025 Feb 22. doi: 10.1038/s41388-025-03309.
    

    >> Share

    
    
17. VALIMA E, Varis V, Bureiko K, Lempiainen JK, et al
    SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells.
    Oncogene. 2025 Feb 14. doi: 10.1038/s41388-025-03305.
    

    >> Share

    
    
18. ZHANG J, Zhai J, Wong CC, Chen H, et al
    Correction: A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML).
    Oncogene. 2025 Feb 12. doi: 10.1038/s41388-025-03304.
    

    >> Share

    
    November 2024
19. DUAN C, Lin X, Zou W, He Q, et al
    Targeting DDX3X eliminates leukemia stem cells in chronic myeloid leukemia by blocking NT5DC2 mRNA translation.
    Oncogene. 2024 Nov 8. doi: 10.1038/s41388-024-03215.
    

    >> Share

    
    
20. ZHANG C, Hao T, Bortoluzzi A, Chen MH, et al
    Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential.
    Oncogene. 2024 Nov 1. doi: 10.1038/s41388-024-03197.
    

    >> Share

    
    August 2024
21. SERGIO I, Varricchio C, Patel SK, Del Gaizo M, et al
    Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL.
    Oncogene. 2024;43:2535-2547.
    

    >> Share

    
    June 2024
22. WANG G, Zhang W, Ren J, Zeng Y, et al
    The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
    Oncogene. 2024;43:1900-1916.
    

    >> Share

    
    April 2024
23. SAFFERTHAL C, Rohde K, Fulda S
    Correction: Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
    Oncogene. 2024 Apr 29. doi: 10.1038/s41388-024-03022.
    

    >> Share

    
    March 2024
24. GUO T, Wang Y, Sun X, Hou S, et al
    Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1.
    Oncogene. 2024 Mar 21. doi: 10.1038/s41388-024-03006.
    

    >> Share

    
    December 2023
25. LEI H, Xu H, Yang L, Wang Y, et al
    USP47 stabilizes YBX1 to promote the progression of acute myeloid leukemia.
    Oncogene. 2023 Dec 16. doi: 10.1038/s41388-023-02921.
    

    >> Share

    
    
26. NOURA M, Matsuo H, Yasuda T, Tsuzuki S, et al
    Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
    Oncogene. 2023 Dec 15. doi: 10.1038/s41388-023-02913.
    

    >> Share

    
    
27. DI MAMBRO A, Arroyo-Berdugo Y, Fioretti T, Randles M, et al
    SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML.
    Oncogene. 2023;42:3670-3683.
    

    >> Share

    
    November 2023
28. ERKNER E, Hentrich T, Schairer R, Fitzel R, et al
    The ROR?/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia.
    Oncogene. 2023 Nov 29. doi: 10.1038/s41388-023-02903.
    

    >> Share

    
    October 2023
29. XIE X, Zhang W, Zhou X, Xu B, et al
    Low doses of IFN-gamma maintain self-renewal of leukemia stem cells in acute myeloid leukemia.
    Oncogene. 2023 Oct 23. doi: 10.1038/s41388-023-02874.
    

    >> Share

    
    September 2023
30. MA H, Cui J, Liu Z, Fang W, et al
    Blockade of de novo pyrimidine biosynthesis triggers autophagic degradation of oncoprotein FLT3-ITD in acute myeloid leukemia.
    Oncogene. 2023 Sep 26. doi: 10.1038/s41388-023-02848.
    

    >> Share

    
    
31. PAWLIKOWSKA P, Delestre L, Gregoricchio S, Oppezzo A, et al
    FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations.
    Oncogene. 2023;42:2764-2775.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share